Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-May-24 1:34 PM View:  | Yanez Michelle Director | Commonwealth Biotechnologie... (INTI) | 01-Apr-24 | Grant | 50,000 | -- | -- | 6% 846.27K to 896.27K | |
| 16-May-24 1:34 PM View: | Jerman Michael Allen Director | Commonwealth Biotechnologie... (INTI) | 01-Apr-24 | Grant | 50,000 | -- | -- | 164% 30.41K to 80.41K | |
| 16-May-24 1:34 PM View: | Sears Samuel P Jr Director | Commonwealth Biotechnologie... (INTI) | 01-Apr-24 | Grant | 50,000 | -- | -- | 5% 1.08M to 1.13M | |
| 16-May-24 1:34 PM View: | Osman Ronald E Director 10% Owner | Commonwealth Biotechnologie... (INTI) | 01-Apr-24 | Grant Duplicate | 50,000 | -- | -- | < 1% 23.52M to 23.57M | |
| 29-Aug-23 3:49 PM View: | Osman Ronald E Director 10% Owner | Commonwealth Biotechnologie... (INTI) | 11-Aug-23 | Grant | 25,000 | -- | -- | < 1% 23.49M to 23.52M | |
| 17-May-23 7:46 PM View: | McNulty James A See Remarks 10% Owner | Commonwealth Biotechnologie... (INTI) | 05-May-23 | Disposition (other) | 79,627,104 | -- | -- | (75%) 106.67M to 27.05M | |
| 17-May-23 7:46 PM View: | McNulty James A See Remarks 10% Owner | Commonwealth Biotechnologie... (INTI) | 05-May-23 | Acquisition (other) | 398,135 | -- | -- | < 1% 86.18M to 86.57M | |
| 17-May-23 7:09 PM View: | Yanez Michelle Director | Commonwealth Biotechnologie... (INTI) | 05-May-23 | Acquisition (other) | 796,271 | -- | -- | 18089% 4.4K to 800.67K | |
| 17-May-23 7:46 PM View: | McNulty James A See Remarks 10% Owner | Commonwealth Biotechnologie... (INTI) | 05-May-23 | Acquisition (other) | 20,101,100 | -- | -- | 23% 86.57M to 106.67M | |
| 19-Jan-21 1:50 PM View: | Mayne Pharma Ventures Pty Ltd 10% Owner | Commonwealth Biotechnologie... (INTI) | 15-Jan-21 | Acquisition (other) | 2,240,490 | -- | -- | 1% 201.84M to 204.08M | |
| 20-Jul-20 9:56 PM View: | Mayne Pharma Ventures Pty Ltd 10% Owner | Commonwealth Biotechnologie... (INTI) | 15-Jul-20 | Acquisition (other) | 3,189,690 | -- | -- | 2% 198.65M to 201.84M | |
| 10-Feb-20 10:00 PM View: | Watson W. Mark Director | Commonwealth Biotechnologie... (INTI) | 12-Dec-19 | Purchase | 500 | $0.06 | $30.95 | < 1% 1.05M to 1.05M | |
| 02-Dec-19 8:57 PM View: | Hasara Garrison J. CFO and Treasurer | Commonwealth Biotechnologie... (INTI) | 02-Dec-19 | Purchase | 13,500 | $0.07 | $945.00 | < 1% 3.96M to 3.97M | |
| 24-Jan-19 7:49 PM View: | Mayne Pharma Ventures Pty Ltd 10% Owner | Commonwealth Biotechnologie... (INTI) | 15-Jan-19 | Acquisition (other) | 362,121 | -- | -- | < 1% 198.29M to 198.65M | |
| 26-Dec-18 5:15 PM View: | Magrab Brandan Director | Commonwealth Biotechnologie... (INTI) | 20-Dec-18 | Grant | 65,000 | $0.08 | $5,200.00 | 100% 0 to 65.0K | |
| 26-Dec-18 5:15 PM View: | Martin Robert Daniel Director | Commonwealth Biotechnologie... (INTI) | 20-Dec-18 | Grant | 60,000 | $0.08 | $4,800.00 | 107% 56.0K to 116.0K | |
| 31-Aug-18 4:30 PM View: | Hasara Garrison J. CFO and Treasurer | Commonwealth Biotechnologie... (INTI) | 30-Aug-18 | Sale | 100,000 | $0.27 | $27,000.00 | (2%) 4.06M to 3.96M | |
| 19-Dec-18 6:09 AM View: | Mayne Pharma Ventures Pty Ltd 10% Owner | Commonwealth Biotechnologie... (INTI) | 15-Jul-18 | Acquisition (other) | 184,798 | -- | -- | < 1% 198.11M to 198.29M | |
| 12-Feb-18 8:00 PM View: | Cross Stefan Director | Commonwealth Biotechnologie... (INTI) | 19-Dec-17 | Purchase | 600,000 | $162,660.00 | $97,595,998,208.00 | (100%) 600.0K to 0 | |
| 12-Feb-18 7:47 PM View: | Mayne Pharma Ventures Pty Ltd 10% Owner | Commonwealth Biotechnologie... (INTI) | 19-Dec-17 | Purchase | 600,000 | $162,660.00 | $97,595,998,208.00 | < 1% 197.51M to 198.11M | |
| 12-Jul-17 4:05 PM View: | Hedgepath, LLC 10% Owner | Commonwealth Biotechnologie... (INTI) | 30-Jun-17 | Sale | 2,500,000 | -- | -- | (3%) 82.13M to 79.63M | |
| 10-Mar-17 4:19 PM View: | Watson W. Mark Director | Commonwealth Biotechnologie... (INTI) | 08-Mar-17 | Payment of Exercise | 356,400 | $0.34 | $121,176.00 | (39%) 910.0K to 553.6K | (36%) |
| 10-Mar-17 4:17 PM View: | Hasara Garrison J. CFO and Treasurer | Commonwealth Biotechnologie... (INTI) | 08-Mar-17 | Payment of Exercise | 2,940,960 | $0.34 | $999,925.00 | (42%) 7.0M to 4.06M | (36%) |
| 10-Mar-17 4:19 PM View: | Watson W. Mark Director | Commonwealth Biotechnologie... (INTI) | 08-Mar-17 | Option Exercise | 900,000 | -- | -- | 9000% 10.0K to 910.0K | |
| 10-Mar-17 4:15 PM View: | Ono Richard Dana Director | Commonwealth Biotechnologie... (INTI) | 08-Mar-17 | Payment of Exercise | 297,000 | $0.34 | $100,980.00 | (40%) 750.0K to 453.0K | (36%) |
| 10-Mar-17 4:16 PM View: | Virca Nicholas J President and CEO | Commonwealth Biotechnologie... (INTI) | 08-Mar-17 | Payment of Exercise | 6,314,220 | $0.34 | $2,146,830.00 | (42%) 15.04M to 8.73M | (36%) |
| 10-Mar-17 4:17 PM View: | Hasara Garrison J. CFO and Treasurer | Commonwealth Biotechnologie... (INTI) | 08-Mar-17 | Option Exercise | 7,000,000 | -- | -- | 100% 0 to 7.0M | |
| 10-Mar-17 4:15 PM View: | Cross Stefan Director | Commonwealth Biotechnologie... (INTI) | 08-Mar-17 | Option Exercise | 600,000 | -- | -- | 100% 0 to 600.0K | |
| 10-Mar-17 4:15 PM View: | Ono Richard Dana Director | Commonwealth Biotechnologie... (INTI) | 08-Mar-17 | Option Exercise | 750,000 | -- | -- | 100% 0 to 750.0K | |
| 10-Mar-17 4:16 PM View: | Virca Nicholas J President and CEO | Commonwealth Biotechnologie... (INTI) | 08-Mar-17 | Option Exercise | 15,041,700 | -- | -- | 100% 0 to 15.04M | |
| 15-Nov-16 9:06 PM View: | Mayne Pharma Ventures Pty Ltd 10% Owner | Commonwealth Biotechnologie... (INTI) | 15-Nov-16 | Exercise (in-the money or at-the-money) | 9,610,900 | -- | -- | 5% 187.9M to 197.51M | |
| 07-Nov-16 9:17 PM View: | Mayne Pharma Ventures Pty Ltd 10% Owner | Commonwealth Biotechnologie... (INTI) | 04-Nov-16 | Exercise (in-the money or at-the-money) | 38,833,000 | -- | -- | 26% 149.06M to 187.9M | |
| 17-Jun-16 5:49 PM View: | Odonnell Francis E Jr Executive Chairman Director | Commonwealth Biotechnologie... (INTI) | 15-Jun-16 | Sale Duplicate | 2,560,000 | -- | -- | (18%) 14.0M to 11.44M | |
| 20-Jun-16 4:10 PM View: | Hedgepath, LLC 10% Owner | Commonwealth Biotechnologie... (INTI) | 15-Jun-16 | Sale | 2,560,000 | -- | -- | (3%) 84.69M to 82.13M | |
| 08-Jun-16 7:00 PM View: | Odonnell Francis E Jr Executive Chairman Director | Commonwealth Biotechnologie... (INTI) | 06-Jun-16 | Disposition (other) | 6,000,000 | -- | -- | (30%) 20.0M to 14.0M | |
| 27-May-16 12:53 PM View: | Mayne Pharma Group Ltd 10% Owner | Commonwealth Biotechnologie... (INTI) | 25-May-16 | Grant | 27,885,000 | -- | -- | 23% 121.18M to 149.06M | |
| 14-Sep-15 4:30 PM View: | Odonnell Francis E Jr Executive Chairman Director | Commonwealth Biotechnologie... (INTI) | 10-Sep-15 | Purchase | 20,000,000 | -- | -- | 100% 0 to 20.0M | |
| 14-Sep-15 4:31 PM View: | Hedgepath, LLC 10% Owner | Commonwealth Biotechnologie... (INTI) | 10-Sep-15 | Sale | 20,000,000 | -- | -- | (19%) 104.69M to 84.69M | |
| 19-May-15 4:58 PM View: | Mayne Pharma Group Ltd 10% Owner | Commonwealth Biotechnologie... (INTI) | 15-May-15 | Grant | 33,333,300 | -- | -- | 38% 87.84M to 121.18M | |
| 09-Sep-14 5:00 PM View: | Watson W. Mark Director | Commonwealth Biotechnologie... (INTI) | 08-Sep-14 | Market Purchase | 10,000 | $0.13 | $1,300.00 | 100% 0 to 10.0K | 16902% |
| 14-Sep-15 4:31 PM View: | Hedgepath, LLC 10% Owner | Commonwealth Biotechnologie... (INTI) | 14-Aug-14 | Conversion | 82,156,800 | -- | -- | 365% 22.53M to 104.69M | |
| 19-Apr-13 12:27 PM View: | Freer Richard J Chief Executive Officer Director 10% Owner | Commonwealth Biotechnologie... (INTI) | 12-Apr-13 | Acquisition (other) | 2,846,720 | $0.05 | $130,095.00 | 61% 4.64M to 7.49M | |
| 19-Apr-13 12:27 PM View: | Sears Samuel P Jr Director | Commonwealth Biotechnologie... (INTI) | 12-Apr-13 | Acquisition (other) | 372,263 | $0.05 | $17,012.40 | 58% 643.84K to 1.02M | |
| 07-Sep-12 2:37 PM View: | Freer Richard J Chief Executive Officer Director 10% Owner | Commonwealth Biotechnologie... (INTI) | 22-Aug-12 | Acquisition (other) | 2,025,000 | $0.02 | $40,500.00 | 77% 2.61M to 4.64M | 572192% |
| 21-Jan-10 3:58 PM View: | d'Sylva Paul Director | Commonwealth Biotechnologie... (INTI) | 19-Jan-10 | Market Sale | 19,100 | $0.50 | $9,550.00 | (7%) 290.32K to 271.22K | (21439%) |
| 01-Jun-09 10:00 PM View: | d'Sylva Paul Director | Commonwealth Biotechnologie... (INTI) | 29-May-09 | Market Purchase | 12,000 | $0.40 | $4,800.00 | 4% 278.32K to 290.32K | 29475% |
| 18-May-09 9:59 AM View: | d'Sylva Paul Director | Commonwealth Biotechnologie... (INTI) | 15-May-09 | Market Purchase | 510 | $0.38 | $193.80 | < 1% 277.81K to 278.32K | 31033% |
| 18-May-09 9:59 AM View: | d'Sylva Paul Director | Commonwealth Biotechnologie... (INTI) | 14-May-09 | Market Purchase | 2,800 | $0.40 | $1,120.00 | 1% 275.01K to 277.81K | 29456% |
| 05-May-09 5:36 PM View: | d'Sylva Paul Director | Commonwealth Biotechnologie... (INTI) | 05-May-09 | Market Purchase | 23,934 | $0.35 | $8,376.90 | 10% 251.07K to 275.01K | 26034% |
| 05-May-09 5:36 PM View: | d'Sylva Paul Director | Commonwealth Biotechnologie... (INTI) | 04-May-09 | Market Purchase | 500 | $0.35 | $175.00 | < 1% 250.57K to 251.07K | 26034% |
